Best of the AUA 2002: Female urology and incontinence

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.

"The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.

In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.

The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.

"I think [gepotidacin] gives a different side effect profile available to the clinicians, and I think for patients as well, it provides a better, more durable option over time," says Ryan Haumschild, PharmD, MS, MBA, CPEL.